Jupiter Asset Management LTD Aurinia Pharmaceuticals Inc. Transaction History

Jupiter Asset Management LTD

  • $9.81 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$4.81 - $5.78 $425,949 - $511,847
-88,555 Reduced 35.84%
158,497 $905,000
Q1 2024

May 10, 2024
BUY
$4.93 - $9.31 $213,794 - $403,737
43,366 Added 21.29%
247,052 $1.24 Million
Q4 2023

Feb 09, 2024
BUY
$7.13 - $9.49 $1.23 Million - $1.64 Million
172,411 Added 551.27%
203,686 $1.83 Million
Q3 2023

Nov 09, 2023
SELL
$7.77 - $12.27 $523,814 - $827,182
-67,415 Reduced 68.31%
31,275 $243,000
Q2 2023

Aug 10, 2023
BUY
$8.96 - $11.69 $884,262 - $1.15 Million
98,690 New
98,690 $955,000

Others Institutions Holding AUPH

# of Institutions
223
Shares Held
59.4M
Call Options Held
1.17M
Put Options Held
1.54M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.13B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email